Skip to content
10-Q

Quarterly Report

Phathom Pharmaceuticals, Inc. PHAT

0001193125-25-257390

← back to feed
Filed
Oct 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 27, 2025 71.14M sh
Shares Diluted Q3 2025 · Sep 30, 2025 73.4M sh
Shares Diluted Q3 2025 · Sep 30, 2025 72.62M sh
Shares Diluted Q3 2025 · Sep 30, 2024 64.63M sh
Shares Diluted Q3 2025 · Sep 30, 2024 60.54M sh
Capex Q3 2025 · Sep 30, 2025 $142K
Capex Q3 2025 · Sep 30, 2024 $130K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$161.77M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$203.31M
Long Term Debt Q3 2025 · Sep 30, 2025 $207.09M
Long Term Debt Q3 2025 · Dec 31, 2024 $201.41M
Short Term Debt Q3 2025 · Sep 30, 2025 $0
Short Term Debt Q3 2025 · Dec 31, 2024 $0
Cash And Equivalents Q3 2025 · Sep 30, 2025 $135.16M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $297.26M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$422.53M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$405.83M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$338.38M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$253.58M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$187.11M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$233.83M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$148.5M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$72.76M
Current Liabilities Q3 2025 · Sep 30, 2025 $93.12M
Current Liabilities Q3 2025 · Dec 31, 2024 $85.73M
Total Liabilities Q3 2025 · Sep 30, 2025 $662.82M
Total Liabilities Q3 2025 · Dec 31, 2024 $631.9M
Current Assets Q3 2025 · Sep 30, 2025 $207.78M
Current Assets Q3 2025 · Dec 31, 2024 $360.13M
Total Assets Q3 2025 · Sep 30, 2025 $240.29M
Total Assets Q3 2025 · Dec 31, 2024 $378.32M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.41
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.76
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.32
Eps Diluted Q3 2025 · Sep 30, 2024 −$4.29
Eps Basic Q3 2025 · Sep 30, 2025 −$0.41
Eps Basic Q3 2025 · Sep 30, 2025 −$2.76
Eps Basic Q3 2025 · Sep 30, 2024 −$1.32
Eps Basic Q3 2025 · Sep 30, 2024 −$4.29
Sga Expense Q3 2025 · Sep 30, 2025 $51.56M
Sga Expense Q3 2025 · Sep 30, 2025 $231.35M
Sga Expense Q3 2025 · Sep 30, 2024 $76.1M
Sga Expense Q3 2025 · Sep 30, 2024 $213.98M
Rd Expense Q3 2025 · Sep 30, 2025 $7.03M
Rd Expense Q3 2025 · Sep 30, 2025 $25.29M
Rd Expense Q3 2025 · Sep 30, 2024 $8.69M
Rd Expense Q3 2025 · Sep 30, 2024 $25.5M
Net Income Q3 2025 · Sep 30, 2025 −$29.97M
Net Income Q3 2025 · Sep 30, 2025 −$200.1M
Net Income Q3 2025 · Jun 30, 2025 −$75.81M
Net Income Q3 2025 · Mar 31, 2025 −$94.32M
Net Income Q3 2025 · Sep 30, 2024 −$85.58M
Net Income Q3 2025 · Sep 30, 2024 −$259.88M
Net Income Q3 2025 · Jun 30, 2024 −$91.45M
Net Income Q3 2025 · Mar 31, 2024 −$82.85M
Operating Income Q3 2025 · Sep 30, 2025 −$15.27M
Operating Income Q3 2025 · Sep 30, 2025 −$154.06M
Operating Income Q3 2025 · Sep 30, 2024 −$70.8M
Operating Income Q3 2025 · Sep 30, 2024 −$218.05M
Gross Profit Q3 2025 · Sep 30, 2025 $43.31M
Gross Profit Q3 2025 · Sep 30, 2025 $102.58M
Gross Profit Q3 2025 · Sep 30, 2024 $14M
Gross Profit Q3 2025 · Sep 30, 2024 $21.43M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $6.19M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $14.95M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $2.36M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $4.16M
Revenue Q3 2025 · Sep 30, 2025 $49.5M
Revenue Q3 2025 · Sep 30, 2025 $117.53M
Revenue Q3 2025 · Sep 30, 2024 $16.35M
Revenue Q3 2025 · Sep 30, 2024 $25.59M